Clinical Trials Browser

Pancreatic Ductal Adenocarcinoma (PDAC) × Irinotecan × Gastrointestinal × Clear all

NCT02782182 2019-03-19

Perioperative FOLFIRINOX for Patients With Resectable Pancreatic Adenocarcinoma: A Pilot Study

Phase 1 Terminated

Gastrointestinal

Pancreatic Ductal Adenocarcinoma (PDAC)